Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression ; volume:13 ; number:1 ; day:6 ; month:7 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (6.7.2023), 1-10, 12.2023

Creator: Ye, Bingyu
Yu, Mengli
Yue, Meijuan
Yin, Man
Zhang, Chunyan
Wang, Qiwen
Ding, Xinru
Shen, Wenlong
Zhao, Zhihu

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-38144-3

URN: urn:nbn:de:101:1-2023100509180405642834

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ye, Bingyu
Yu, Mengli
Yue, Meijuan
Yin, Man
Zhang, Chunyan
Wang, Qiwen
Ding, Xinru
Shen, Wenlong
Zhao, Zhihu
SpringerLink (Online service)

Other Objects (12)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Epigenetic regulation during hepatic stellate cell activation

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis

The role of Semaphorin 3C in the activation of hepatic stellate cells and liver fibrosis

Related objects

Reset password